This study is for the treatment of localized, muscle-invasive bladder cancer

This study is for the treatment of localized, muscle-invasive bladder cancer.

Study phase: II

Primary disease category: Cancer

Secondary disease categories: Cancer, Bladder Cancer, Kidney & Urinary Tract

Sponsor: Southwest Oncology Group (SWOG) / National Cancer Institute (NCI)

Protocol number: S1314

Projected enrollment dates: December 2014 to December 2018

Official study title: A RANDOMIZED PHASE II STUDY OF CO-EXPRESSION EXTRAPOLATION (COXEN) WITH NEOADJUVANT CHEMOTHERAPY FOR LOCALIZED, MUSCLE-INVASIVE BLADDER CANCER (S1314)